Home » Topics » BioWorld Science

BioWorld Science
RSS

Leidos Biomedical Research and the University of California describe RAS GTPase inhibitors

Nov. 15, 2018

National University of Singapore and collaborators patent BAD inhibitors

Nov. 15, 2018

Obesity is net positive for checkpoint blockers

Nov. 15, 2018

MSC-derived EVs contribute to aortic tissue repair and remodeling in aortic aneurysm via miR-147

Nov. 15, 2018

Blocking BigLEN-GRP171 signaling reduces opioid addiction and withdrawal in mice

Nov. 15, 2018

Shifa Biomedical presents data on new PCSK9 inhibitor P-21

Nov. 15, 2018

Prior experience and OX2 receptor activation is linked to social stress resilience

Nov. 15, 2018

AEG-1 as a promising new therapeutic target in Parkinson's disease

Nov. 15, 2018

MYK-581 leads to contractile regulation with improved compliance and functional reserve in HCM model

Nov. 15, 2018

KemPharm adds drug for stimulant use disorder to pipeline

Nov. 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...